â??A three arm open label trial comparing minoxidil 5 percent solution and oral biotin VERSUS minoxidil 5 percent and finasteride 0.1 percent and oral placebo VERSUS minoxidil 5 percent and oral placebo in the management of male pattern hair lossâ??
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2021/04/033083
- Lead Sponsor
- RESEARCH CELL ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients who give informed written consent and fulfilling all the following criteria will be included in the study
1.Age more than or equal to 18 years and less than or equal to 50 years
2.Clinical diagnosis of androgenic alopecia.
3.Grade I, II , III , III vertex and IV of Hamilton Norwood grading.
Patient having any of the following criteria will be excluded from the study.
1.Known sensitivity to either topical minoxidil or topical finasteride or oral biotin.
2.Known hypotensive
3.Inability to take oral medications.
4.Uncontrolled gastrointestinal infection/malabsorption syndrome
5.Had used topical minoxidil/topical finasteride/oral supplement/oral herbal extract/any OTC medication for hair growth within the past 1 month
6.Patients with diffuse hair loss (telogen effluvium)
7.Patient with scarring alopecias
8.Patient with severe/uncontrolled scalp diseases-seborrheic dermatitis, scalp infection, scalp psoriasis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method